Humana, Stryker, Boston Scientific, Danaher, and Hims & Hers Health are the five Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks are shares of companies involved in healthcare, such as pharmaceutical and biotech firms, medical-device makers, and healthcare providers. For investors, they offer exposure to the healthcare sector, whose performance can be influenced by factors such as research results, regulation, and demand for medical care. These companies had the highest dollar trading volume of any Medical stocks within the last several days.
Humana (HUM)
Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Humana stock traded up $7.29 during mid-day trading on Wednesday, hitting $445.35. The stock had a trading volume of 933,888 shares, compared to its average volume of 1,644,822. Humana has a one year low of $163.11 and a one year high of $456.50. The company has a current ratio of 1.65, a quick ratio of 1.74 and a debt-to-equity ratio of 0.61. The firm has a market capitalization of $53.48 billion, a P/E ratio of 43.35, a P/E/G ratio of 2.46 and a beta of 0.65. The firm's 50 day moving average is $405.76 and its 200 day moving average is $313.90.
Read Our Latest Research Report on HUM
Stryker (SYK)
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.
NYSE:SYK traded down $5.34 on Wednesday, reaching $318.95. 1,077,063 shares of the company's stock traded hands, compared to its average volume of 2,507,728. The stock has a 50-day simple moving average of $292.25 and a 200-day simple moving average of $323.23. Stryker has a 12 month low of $267.00 and a 12 month high of $389.33. The firm has a market cap of $121.42 billion, a PE ratio of 33.99, a P/E/G ratio of 2.24 and a beta of 0.78. The company has a quick ratio of 1.30, a current ratio of 2.18 and a debt-to-equity ratio of 0.60.
Read Our Latest Research Report on SYK
Boston Scientific (BSX)
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system.
Shares of NYSE BSX traded up $0.80 during mid-day trading on Wednesday, reaching $45.50. The company's stock had a trading volume of 7,117,982 shares, compared to its average volume of 18,745,629. The stock has a fifty day moving average of $44.19 and a two-hundred day moving average of $55.23. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.36 and a quick ratio of 0.81. Boston Scientific has a 52 week low of $39.57 and a 52 week high of $105.65. The firm has a market capitalization of $65.95 billion, a PE ratio of 19.30, a P/E/G ratio of 1.30 and a beta of 0.60.
Read Our Latest Research Report on BSX
Danaher (DHR)
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
DHR traded down $0.02 during trading on Wednesday, reaching $236.09. 1,349,040 shares of the company traded hands, compared to its average volume of 4,432,552. The company has a market cap of $166.10 billion, a P/E ratio of 38.63, a PEG ratio of 2.95 and a beta of 0.76. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.29 and a current ratio of 1.63. Danaher has a 12-month low of $160.93 and a 12-month high of $242.80. The firm has a fifty day simple moving average of $221.10 and a 200 day simple moving average of $201.55.
Read Our Latest Research Report on DHR
Hims & Hers Health (HIMS)
Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.
Shares of NYSE:HIMS traded up $1.31 during midday trading on Wednesday, reaching $20.44. 13,044,599 shares of the company were exchanged, compared to its average volume of 22,359,475. The stock has a market cap of $4.77 billion, a PE ratio of -24.61 and a beta of 2.53. The business's fifty day moving average is $28.10 and its two-hundred day moving average is $26.85. The company has a current ratio of 0.93, a quick ratio of 0.87 and a debt-to-equity ratio of 4.21. Hims & Hers Health has a one year low of $13.74 and a one year high of $40.99.
Read Our Latest Research Report on HIMS
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Humana, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Humana wasn't on the list.
While Humana currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
